Downregulation of insulin transport through the blood–brain barrier (BBB) and dysregulation of the insulin receptor (IR) intracellular cascade that occur in patients with DM are associated with a higher risk of Alzheimer’s disease (AD) because of Aβ peptide accumulation and increased neuronal tau protein phosphorylation [15]. This evidence concerns the gene INS and Alzheimer disease.